{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:12:45Z","timestamp":1779257565588,"version":"3.51.4"},"reference-count":82,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s590462","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:50:13Z","timestamp":1779256213000},"page":"1-12","source":"Crossref","is-referenced-by-count":0,"title":["The Socioeconomic Impact of Long-Acting Injectable Buprenorphine"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Samuel","family":"Rasche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Batchelor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharine","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7841-9245","authenticated-orcid":true,"given":"Harry","family":"Sumnall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-5460","authenticated-orcid":true,"given":"Daniel","family":"Mogford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(17)31869-X","volume":"391","author":"Aldridge","year":"2018","journal-title":"Lancet"},{"key":"ref3","unstructured":"Office for Health Improvement & Disparities. Adult substance misuse treatment statistics 2022 to 2023: report. 2023."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13034-019-0266-3","volume":"13","author":"Romanowicz","year":"2019","journal-title":"Child Adolesc Psychiatr Ment Health"},{"key":"ref5","unstructured":"Misuse of drugs act. 1971."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e180558","DOI":"10.1001\/jamanetworkopen.2018.0558","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.drugalcdep.2017.07.024","volume":"179","author":"Pierce","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13011-021-00417-3","volume":"16","author":"Garpenhag","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijerph20021526","volume":"20","author":"Carlisle","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"ref10","unstructured":"Department of Health & Social Care. Oral methadone and buprenorphine: recommendations. 2024."},{"key":"ref11","unstructured":"National Institute for Health and Care Excellence. Methadone and buprenorphine for the management of opioid dependence. 2007. Available from: www.nice.org.uk\/guidance\/ta114. Accessed May 14, 2026."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2882","DOI":"10.1002\/hup.2882","volume":"38","author":"Jones","year":"2023","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"ref13","first-page":"5","volume":"20","author":"Monwell","year":"2018","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1007\/s11606-020-06257-4","volume":"35","author":"Mackey","year":"2020","journal-title":"J Gen Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12954-021-00535-y","volume":"18","author":"Frank","year":"2021","journal-title":"Harm Reduct J"},{"key":"ref16","first-page":"65","volume":"14","author":"Benyamina","year":"2012","journal-title":"Heroin Addict Relat Clin Probl"},{"key":"ref17","unstructured":"National Drug Treatment Monitoring System. Unmet treatment need indicator. 2025. Available from: https:\/\/www.ndtms.net\/. Accessed May 14, 2026."},{"key":"ref18","unstructured":"HM Government. From harm to hope: a 10-year drugs plan to cut crime and save lives. 2021."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"108959","DOI":"10.1016\/j.drugalcdep.2021.108959","volume":"227","author":"Barnett","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13722-024-00458-6","volume":"19","author":"Nordgren","year":"2024","journal-title":"Addiction Sci Clin Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13011-022-00474-2","volume":"17","author":"Johnson","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref22","unstructured":"National Institute for Health and Care Excellence. Opioid dependence: buprenorphine prolonged-release injection (Buvidal): evidence review. 2019."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/17425247.2024.2369756","volume":"21","author":"Rolland","year":"2024","journal-title":"Expert Opin Drug Deliv"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"104255","DOI":"10.1016\/j.drugpo.2023.104255","volume":"123","author":"Bharat","year":"2024","journal-title":"Int J Drug Policy"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/14550725231204723","volume":"41","author":"Prami","year":"2024","journal-title":"Nord Stud Alcohol Drugs"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/bjc\/azh085","volume":"45","author":"Lind","year":"2005","journal-title":"Br J Criminol"},{"key":"ref27","author":"Casey","year":"2009","journal-title":"Scottish Government Soc Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/00027162221142644","volume":"703","author":"Bullinger","year":"2022","journal-title":"Ann Am Acad Pol Soc Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"Santo","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/add.14188","volume":"113","author":"Hickman","year":"2018","journal-title":"Addiction"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","volume":"24","author":"Ma","year":"2019","journal-title":"Mol Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11606-011-1962-8","volume":"27","author":"Schackman","year":"2012","journal-title":"J Gen Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"102311","DOI":"10.1016\/j.eclinm.2023.102311","volume":"66","author":"Marsden","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-025-13607-7","volume":"25","author":"Gauffin","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/14659891.2024.2342313","volume":"30","author":"Mlilo","year":"2025","journal-title":"J Subst Use"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1186\/s12913-022-08687-8","volume":"22","author":"Ling","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/SAR.S510467","volume":"Volume 16","author":"Sayers","year":"2025","journal-title":"Subst Abuse Rehabil"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1055\/a-1842-7164","volume":"85","author":"St\u00f6ver","year":"2023","journal-title":"Das Gesundheitswesen"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/jchc.21.07.0063","volume":"28","author":"Wong","year":"2022","journal-title":"J Correctional Health Care"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-019-0296-4","volume":"16","author":"Neale","year":"2019","journal-title":"Harm Reduct J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/ADM.0000000000000517","volume":"13","author":"Ling","year":"2019","journal-title":"J Addict Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.11.004","volume":"110","author":"Ling","year":"2020","journal-title":"J Subst Abuse Treat"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0140-6736(18)32259-1","volume":"393","author":"Haight","year":"2019","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09687637.2025.2506415","author":"Neale","year":"2025","journal-title":"Drugs"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/SAR.S155843","volume":"10","author":"Ling","year":"2019","journal-title":"Subst Abuse Rehabil"},{"key":"ref47","unstructured":"HM Treasury. The Green Book: Central Government Guidance on Appraisal and Evaluation. Hm Treasury; 2022."},{"key":"ref48","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","year":"2015"},{"key":"ref49","unstructured":"Office for National Statistics. Population estimates for England and Wales: mid-2023. 2024."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/add.14636","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction"},{"key":"ref51","unstructured":"HM Treasury. GDP deflators at market prices, and money GDP June 2025 (Quarterly national accounts). 2025."},{"key":"ref52","unstructured":"Department for Education. Children Looked after in England Including Adoption: 2023 to 2024. 2024."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/lawfam\/eby006","volume":"32","author":"Harwin","year":"2018","journal-title":"Int J Law Policy Family"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1002\/hec.4409","volume":"30","author":"Conti","year":"2021","journal-title":"Health Econ"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/dar.13933","volume":"43","author":"Domzaridou","year":"2024","journal-title":"Drug Alcohol Rev"},{"key":"ref56","unstructured":"National Institute for Health and Care Excellence. Buprenorphine. 2025."},{"key":"ref57","unstructured":"National Institute for Health and Care Excellence. Methadone Hydrochloride. 2025."},{"key":"ref58","unstructured":"Bauld L, Hay G, McKell J, Carroll C. Problem drug users\u2019 experiences of employment and the benefit system. 2010."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"109254","DOI":"10.1016\/j.drugalcdep.2021.109254","volume":"231","author":"Evans","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"ref60","unstructured":"HM Prison & Probation Service. Costs per place and costs per prisoner by individual prison. 2024."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1360-0443.2004.00752.x","volume":"99","author":"Godfrey","year":"2004","journal-title":"Addiction"},{"key":"ref62","unstructured":"Heeks M, Reed S, Tafsiri M, Prince S. The economic and social costs of crime second edition. home office research report 99. 2018."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.childyouth.2006.08.006","volume":"29","author":"Green","year":"2007","journal-title":"Child Youth Serv Rev"},{"key":"ref64","unstructured":"National Fostering Group. Foster care pay and allowances. Available from: https:\/\/www.nfa.co.uk\/thinking-about-fostering\/support-and-benefits-for-foster-carers\/financial-support\/. Accessed May 14, 2026."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.dadr.2024.100233","volume":"11","author":"Yarborough","year":"2024","journal-title":"Drug Alcohol Dependence Reports"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"S693","DOI":"10.1016\/j.jval.2019.09.1544","volume":"22","author":"Roncero","year":"2019","journal-title":"Value Health"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","volume":"104","author":"Bell","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"107044","DOI":"10.1016\/j.measurement.2019.107044","volume":"150","author":"Thomas","year":"2020","journal-title":"Measurement"},{"key":"ref70","unstructured":"Office for National Statistics. Deaths related to drug poisoning in England and Wales: 2023 registrations. 2024."},{"key":"ref71","unstructured":"National Institute for Health and Care Excellence. How NICE measures value for money in relation to public health interventions. 2013."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/add.15111","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"key":"ref73","unstructured":"Hay G, Rael Dos Santos A, Reed H, Hope V. Estimates of the prevalence of opiate use and\/or crack cocaine use, 2016\/17: sweep 13 report. 2019."},{"key":"ref74","unstructured":"Office for Health Improvement and Disparities, UK Health Security Agency. Estimates of opiate and crack use in England: main points and methods. 2023."},{"key":"ref75","unstructured":"Office for Health Improvement & Disparities. Alcohol and drug treatment in secure settings 2022 to 2023: report. 2024."},{"key":"ref76","unstructured":"Ministry of Justice & HM Prison and Probation Service. New change to some offenders\u2019 automatic release dates. 2024. Available from: https:\/\/www.gov.uk\/guidance\/new-change-to-some-offenders-automatic-release-dates. Accessed May 14, 2026."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"100328","DOI":"10.1016\/j.dadr.2025.100328","volume":"15","author":"Fish","year":"2025","journal-title":"Drug Alcohol Dependence Reports"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18513","author":"Somaini","year":"2021","journal-title":"Cureus"},{"key":"ref79","unstructured":"Department of Health and Social Care. Supplying take home naloxone without a prescription. 2025. Available from: https:\/\/www.gov.uk\/guidance\/supplying-take-home-naloxone-without-a-prescription. Accessed May 14, 2026."},{"key":"ref80","unstructured":"Home Office. Local preparedness for synthetic opioids in England. 2025. Available from: https:\/\/www.gov.uk\/government\/publications\/local-preparedness-for-synthetic-opioids-in-england\/local-preparedness-for-synthetic-opioids-in-england-accessible. Accessed May 14, 2026."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/CEOR.S242984","volume":"12","author":"Phillips-Jackson","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1080\/03007995.2022.2129230","volume":"38","author":"Pedersen","year":"2022","journal-title":"Curr Med Res Opin"}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/115392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/115392","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:50:26Z","timestamp":1779256226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-socioeconomic-impact-of-long-acting-injectable-buprenorphine-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":82,"URL":"https:\/\/doi.org\/10.2147\/ceor.s590462","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}